Trial Profile
A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid tree pollen.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2011
Price :
$35
*
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis; Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors LETI Pharma GmbH
- 30 Jun 2011 New trial record